Description
Product Description:
Isentress, a breakthrough medication manufactured by MSD Pharmaceuticals Pvt. Ltd., contains 400 mg of Raltegravir in each tablet. Here’s a comprehensive overview of this innovative medication:
1. Active Ingredient: Raltegravir
- Isentress tablets contain Raltegravir, a potent antiretroviral medication belonging to the class of integrase strand transfer inhibitors (INSTIs). Raltegravir works by blocking the action of the integrase enzyme, which is essential for the replication of the human immunodeficiency virus (HIV) within host cells. By inhibiting viral integration into the host genome, Raltegravir effectively suppresses HIV replication and reduces viral load in the body.
2. Medical Indications:
- Isentress is indicated for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 40 kg. It is used in combination with other antiretroviral agents as part of combination antiretroviral therapy (ART) regimens for the management of HIV/AIDS. Isentress is recommended for both treatment-naive and treatment-experienced individuals, including those with multidrug-resistant HIV strains.
3. Strength and Dosage:
- Each tablet of Isentress contains 400 mg of Raltegravir, the recommended dosage for most adult patients. The dosage regimen may vary depending on factors such as the patient’s age, weight, renal function, previous treatment history, and presence of drug-resistant HIV strains. Isentress tablets are typically administered orally twice daily, with or without food, as directed by a healthcare provider.
4. Form and Packaging:
- Isentress tablets are available in a convenient tablet form, packed in a blister pack containing 60 tablets. The blister packaging ensures ease of dispensing, storage, and administration, allowing patients to maintain their HIV treatment regimen with convenience and compliance. Each tablet is film-coated for easy swallowing and protection from degradation.
5. Manufacturer: MSD Pharmaceuticals Pvt. Ltd.
- Isentress tablets are manufactured by MSD Pharmaceuticals Pvt. Ltd., a leading pharmaceutical company committed to advancing healthcare through innovation and excellence. MSD Pharmaceuticals Pvt. Ltd. adheres to stringent quality standards and regulatory guidelines to ensure the safety, efficacy, and reliability of its products, including Isentress.
6. Benefits:
- Isentress offers several benefits for patients with HIV infection, including potent antiviral activity, durable virologic suppression, and a favorable side effect profile. By effectively inhibiting HIV replication and reducing viral load, Isentress helps improve immune function, reduce the risk of opportunistic infections, and delay disease progression in individuals living with HIV/AIDS.
7. Precautions:
- While Isentress is generally well-tolerated, it may cause certain side effects such as headache, nausea, diarrhea, and elevated liver enzymes. Patients should be monitored regularly for signs of adverse reactions, and any unusual symptoms should be reported to a healthcare provider promptly. Isentress may interact with certain medications, so it is essential to inform the healthcare provider about all current medications, including prescription drugs, over-the-counter products, and supplements, before starting treatment.
Isentress tablets, containing Raltegravir as the active ingredient and manufactured by MSD Pharmaceuticals Pvt. Ltd., represent a cornerstone in the management of HIV infection. With its potent antiviral activity, convenient dosing regimen, and reliable efficacy, Isentress plays a crucial role in suppressing viral replication, improving immune function, and enhancing the quality of life for patients living with HIV/AIDS.
Reviews
There are no reviews yet.